By continuing to use the site you agree to our Privacy & Cookies policy

Your browser seems to have cookies disabled. For the best experience of this website, please enable cookies in your browser.


Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.


Routes from cancer diagnosis – new research published

Macmillan’s Routes from Diagnosis report reveals big variation in survival outcomes, morbidity and cost between patient groups for breast, prostate, lung and brain cancers in England.

Despite the fact that one and five-year survival rates for breast and prostate cancer have improved significantly, this research shows only 20% of women with breast cancer, and 25% of men with prostate cancer will survive long term and in good health.

Macmillan is using this evidence to urge medical leaders and decision makers to lead a shift away from one-size-fits-all care for cancer survivors, and towards more personalised care.

Read the report here.

Have your say

You must sign in to make a comment.

Related Jobs

Sign in to see the latest jobs relevant to you!